Elevated A1C in adults without a history of diabetes in the U.S

Elizabeth Selvin, Hong Zhu, Frederick L Brancati, Elizabeth Selvin, Hong Zhu, Frederick L Brancati

Abstract

Objective: The purpose of this study was to examine the prevalence and correlates of elevated A1C in a large, nationally representative sample of adults without diabetes in the U.S.

Research design and methods: We analyzed data from 15,934 participants aged >or=20 years without diagnosed diabetes who had A1C measurements in the 1999-2006 National Health and Nutrition Examination Survey, a cross-sectional and nationally representative sample of the U.S. population.

Results: The overall prevalence of A1C >6% was 3.8%, corresponding to 7.1 million adults without diabetes in the U.S. population. Approximately 90% of these individuals had fasting glucose >or=100 mg/dl. Older age, male sex, non-Hispanic black race/ethnicity, hypercholesterolemia, higher BMI, and lower attained education were significantly associated with having a higher A1C level even among individuals with normal fasting glucose (<100 mg/dl) and after multivariable adjustment.

Conclusions: A single elevated A1C level (A1C >6%) is common in the general population of adults without a history of diabetes and is highly reliable for the detection of elevated fasting glucose. Nondiabetic adults with elevated A1C are likely to have impaired fasting glucose and an array of other risk factors for type 2 diabetes and cardiovascular disease.

Figures

Figure 1
Figure 1
Count in millions (95% CI) of persons at different A1C cut points in the U.S. 2000 Census population aged ≥20 years without diabetes.
Figure 2
Figure 2
Weighted smoothed histogram comparing distributions of A1C by fasting glucose category, adults aged ≥20 years without diagnosed diabetes, U.S. 1992–2006.

References

    1. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ: Utility of hemoglobin A1c in predicting diabetes risk. J Gen Internal Med 2004; 19: 1175– 1180
    1. Ko GT, Chan JC, Tsang LW, Cockram CS: Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care 2000; 23: 1770– 1773
    1. Pradhan AD, Rifai N, Buring JE, Ridker PM: Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007; 120: 720– 727
    1. Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E: the DESIR Study Group. Use of HbA1c in predicting progression to diabetes in french men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006; 29: 1619– 1625
    1. Inoue K, Matsumoto M, Kobayashi Y: The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers. Diabetes Res Clin Pract 2007; 77: 451– 458
    1. Levitan EB, Song Y, Ford ES, Liu S: Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 2004; 164: 2147– 2155
    1. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N: Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141: 413– 420
    1. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW: Glycemic control and coronary heart disease risk in persons with and without diabetes: the Atherosclerosis Risk in Communities Study. Arch Intern Med 2005; 165: 1910– 1916
    1. Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, Sharrett AR: Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Lancet Neurol 2005; 4: 821– 826
    1. Levitan EB, Liu S, Stampfer MJ, Cook NR, Rexrode KM, Ridker PM, Buring JE, Manson JE: HbA1C measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia 2008; 51: 267– 275
    1. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB: A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008; 93: 2447– 2453
    1. National Center for Health Statistics, Centers for Disease Control and Prevention. Survey Operations Manuals, Brochures, and Consent Documents: 1999-current NHANES. Available at [article online], 2007. Accessed 6 March 2009
    1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31: S55– S60
    1. National Health and Nutrition Examination Survey 2005–2006. Documentation, Codebook, and Frequencies: glycohemoglobin [article online], 2008. Available from: . Accessed 6 March 2009
    1. National Health and Nutrition Examination Survey 2005–2006. Documentation, Codebook, and Frequencies: plasma fasting glucose and insulin [article online], . Accessed 6 March 2009
    1. National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES) Analytic Guidelines [article online], 2007. Available from: . Accessed 9 May 2007
    1. Selvin E, Crainiceanu CM, Brancati FL, Coresh J: Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007; 167: 1545– 1551
    1. Phillipou G, Phillips PJ: Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals. Clin Chem 1993; 39: 2305– 2308
    1. Buell C, Kermah D, Davidson MB: Utility of A1C for diabetes screening in the 1999–2004 NHANES population. Diabetes Care 2007; 30: 2233– 2235
    1. Davidson MB, Schriger DL, Peters AL, Lorber B: Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 1999; 281: 1203 1210
    1. Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, Flegal KM, Eberhardt MS, Goldstein DE: Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000; 23: 187– 191
    1. Little RR: Glycated hemoglobin standardization—National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med 2003; 41: 1191– 1198
    1. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE: The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001; 47: 1985– 1992
    1. Rohlfing C, Wiedmeyer HM, Little R, Grotz VL, Tennill A, England J, Madsen R, Goldstein D: Biological variation of glycohemoglobin. Clin Chem 2002; 48: 1116– 1118
    1. Bennett CM, Guo M, Dharmage SC: HbA1c as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 2007; 24: 333– 343

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel